Published in J Virol on May 01, 1995
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J Virol (1969) 9.39
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus. J Virol (1982) 6.56
A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (1991) 6.54
Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice. J Exp Med (1972) 5.64
Dilute (d) coat colour mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome. Nature (1981) 4.77
Nucleotide sequence of AKV murine leukemia virus. J Virol (1984) 4.58
Excision of the DBA ecotropic provirus in dilute coat-color revertants of mice occurs by homologous recombination involving the viral LTRs. Cell (1983) 3.66
Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc Natl Acad Sci U S A (1979) 3.64
Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J Virol (1983) 3.07
Virological events leading to spontaneous AKR thymomas. J Virol (1991) 2.45
Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proc Natl Acad Sci U S A (1974) 2.28
At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR mice. J Virol (1985) 2.20
The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol (1987) 2.06
Genetic alterations of RNA leukemia viruses associated with the development of spontaneous thymic leukemia in AKR/J mice. J Virol (1982) 1.79
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70
Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J Virol (1991) 1.70
Association of the lethal yellow (Ay) coat color mutation with an ecotropic murine leukemia virus genome. Proc Natl Acad Sci U S A (1983) 1.60
Molecular and biological characterization of the endogenous ecotropic provirus of BALB/c mice. J Virol (1985) 1.45
Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J Virol (1988) 1.43
Genetic mapping of ecotropic murine leukemia virus-inducing loci in six inbred strains. J Exp Med (1982) 1.40
DNAs of two molecularly cloned endogenous ecotropic proviruses are poorly infectious in DNA transfection assays. J Virol (1984) 1.38
Mechanism of interaction between endogenous ecotropic murine leukemia viruses in (BALB/c X C57BL/6) hybrid cells. Virology (1988) 1.06
Nucleotide conservation of endogenous ecotropic murine leukemia proviruses in inbred mice: implications for viral origin and dispersal. Virology (1987) 1.02
Variants of type-C retroviruses from DBA/2 mice: protein-structural and biological properties. Virology (1983) 0.94
Mechanisms of caloric restriction affecting aging and disease. Ann N Y Acad Sci (1994) 0.93
A murine leukemia virus expressed in aged DBA/2 mice is derived by recombination of the Emv-3 locus and another endogenous gag sequence. Virology (1994) 0.80
Mechanism of chemical activation of expression of the endogenous ecotropic murine leukemia provirus Emv-3. J Virol (1990) 0.79
T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. Nature (1976) 1.99
Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology (1993) 1.92
Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity. Nature (1977) 1.49
Immune response to influenza vaccination in a large healthy elderly population. Vaccine (1999) 1.41
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
Immunologic response in an elderly population with a mean age of 85. Am J Med (1986) 1.22
Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J Immunol (1985) 1.20
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol (1993) 1.14
The genetic basis of susceptibility to leukemia induction in mice by 3-methylcholanthrene applied percutaneously. J Exp Med (1978) 1.14
Cytokine production after influenza vaccination in a healthy elderly population. Vaccine (1998) 1.11
Mechanisms of the H-2 effect on viral leukemogenesis. Scand J Immunol (1977) 1.09
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J Immunol (1983) 1.04
Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine (2001) 1.04
Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma. Cell Immunol (1988) 1.02
A role for complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med (1992) 1.00
Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect Immun (1993) 0.96
Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice. Virology (1993) 0.94
Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol (1994) 0.93
Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol (1992) 0.91
T cell receptor genes and T cell development in virus-transformed early T cell lines. J Immunol (1990) 0.91
Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res (1991) 0.91
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. J Neuroimmunol (1988) 0.90
Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol (1996) 0.90
Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness. J Exp Med (1990) 0.88
The Fv-2r resistance gene in mice: its effect on spleen colony formation by Friend virus-transformed cells. J Natl Cancer Inst (1976) 0.87
Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytodilic acid. Infect Immun (1984) 0.86
Microsatellite typing of CXB recombinant inbred and parental mouse strains. Mamm Genome (1997) 0.86
Apparent lack of H-2 restriction of allograft rejection. J Immunol (1978) 0.85
Environmental lighting alters the infection process in an animal model of AIDS. Pharmacol Biochem Behav (1995) 0.85
Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc. Mech Ageing Dev (2000) 0.85
Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines. J Immunol (1987) 0.85
Effect of Friend leukemia virus infection on susceptibility to Candida albicans. Infect Immun (1990) 0.85
Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev (1996) 0.85
Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization. J Infect Dis (1998) 0.84
Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells. Cell Immunol (1993) 0.84
Monocyte culture and adherence modifies LPS-induced IL-6 production and inhibition by hydrocortisone. Clin Immunol Immunopathol (1994) 0.83
Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis. Adv Exp Med Biol (1987) 0.83
Detection of specific surface antigens on cells transformed by cytomegalovirus with the techniques of mixed hemagglutination and 125I-labeled antiglobulin. J Immunol (1974) 0.83
Evidence that endogenous ecotropic virus is not expressed in AKR thymic lymphoid cells of chimeric hosts. J Exp Med (1980) 0.83
Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon. Cell Immunol (1985) 0.82
The role of vitamin A in natural killer cell cytotoxicity, number and activation in the rat. Nat Immun (1994) 0.82
Age-related changes in interferon-alpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev (2000) 0.82
Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation. J Interferon Res (1985) 0.82
Inhibition of lymphocyte recirculation by murine interferon: effects of various interferon preparations and timing of administration. J Interferon Res (1989) 0.82
Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta. Mech Ageing Dev (2000) 0.81
Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells. J Immunol (1986) 0.81
Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines. Immunogenetics (1981) 0.81
The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anesth Analg (1997) 0.81
Basal natural killer cell activity of young versus elderly humans. J Gerontol A Biol Sci Med Sci (1995) 0.80
Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. J Immunol (1992) 0.80
Heterogeneous effects of exogenous lymphokines on lymphoproliferation of elderly subjects. Mech Ageing Dev (1991) 0.80
Specific infection of central nervous system white matter by a variant of gross murine leukemia virus. Virology (1990) 0.80
In vivo generation of antigenic variants of murine retroviruses. Virology (1989) 0.80
A murine leukemia virus expressed in aged DBA/2 mice is derived by recombination of the Emv-3 locus and another endogenous gag sequence. Virology (1994) 0.80
Cellular immune response to virus-specific antigen in hamsters bearing isografts of cytomegalovirus-transformed cells. Int J Cancer (1974) 0.80
Identification of a variant of gross leukemia virus that induces disease in mice inoculated as adults. J Exp Med (1983) 0.79
Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains. Cell Immunol (1988) 0.79
Altered macrophage antigen-presenting cell function following Friend leukemia virus infection. Viral Immunol (1992) 0.79
The age-associated decline in immune function of healthy individuals is not related to changes in plasma concentrations of beta-carotene, retinol, alpha-tocopherol or zinc. Mech Ageing Dev (1997) 0.79
Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus. J Natl Cancer Inst (1978) 0.79
Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization. Immunogenetics (1999) 0.78
T-kininogen is a biomarker of senescence in rats. Mech Ageing Dev (1998) 0.78
Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16F10L melanoma. Int J Cancer (1990) 0.78
Inhibition of macrophage-induced antigen-specific T lymphocyte proliferation by poly I:C: strain and antigen independence. Cell Immunol (1991) 0.78
The role of T cell phenotypes in decreased lymphoproliferation of the elderly. Clin Immunol Immunopathol (1989) 0.78
Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection. Antiviral Res (1991) 0.78
Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response. Virology (2001) 0.78
Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice. J Immunol (1998) 0.77
Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study. Clin Immunol Immunopathol (1997) 0.77
Inhibition of macrophage-induced, antigen-specific T-cell proliferation by poly I:C role of suppressor macrophages. Immunology (1994) 0.77
Maintenance of normal T lymphocyte function after transfection with SV40 large T. Cell Immunol (1993) 0.77
Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus. J Immunol (1982) 0.77
Effect of age on cytokine production in humans. Age (Omaha) (1998) 0.77
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. Ann N Y Acad Sci (1988) 0.77
Inhibition of virus-induced murine diabetes by an interferon inducer. J Interferon Res (1982) 0.77
Construction of a DBA/2.Fv-2r congenic strain. Apparent lethality of the homozygous Fv-2r genotype: brief communication. J Natl Cancer Inst (1977) 0.77
Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived brown Norway rat. Mech Ageing Dev (1993) 0.77
Murine leukemia virus infection in immunocompetent adult mice. Virology (1993) 0.77
Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus. Virology (1995) 0.77
Extension of lifespan of human T lymphocytes by transfection with SV40 large T antigen. Exp Cell Res (1992) 0.77
Variation in p30-related proteins in gross virus-induced tumor cell lines derived from H-2 congenic mice. J Virol (1984) 0.76
Induction of interferon in AKR mice by murine leukaemia viruses. Nature (1980) 0.76
Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. Clin Immunol Immunopathol (1993) 0.76
Age-associated changes in mitogen-induced lymphoproliferation and lymphokine production in the long-lived brown-Norway rat: effect of caloric restriction. Mech Ageing Dev (1995) 0.76
Evidence for H-2-linked control of retrovirus production in Friend virus-induced tumor cell lines. J Virol (1986) 0.76
Anesthesia inhibits poly I:C induced stimulation of natural killer cell cytotoxicity in mice. Clin Immunol Immunopathol (1990) 0.76
Inhibition of induction of natural killer activity in mice by general anesthesia (Avertin): role of interferon. Clin Immunol Immunopathol (1991) 0.76
Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology (1993) 0.76
Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies. Cancer (1988) 0.75
Ultrastructural study of biochemically modulated ADCC in HSV-1 infected and uninfected Chang liver cells. Microbios (1986) 0.75
Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice. J Virol (1999) 0.75
Production, screening and characterization of a monoclonal antibody to murine interferon-beta. J Gen Virol (1983) 0.75
Effect of anti-interferon serum on Friend virus infection and Fv-1-mediated resistance. J Interferon Res (1981) 0.75